Huapont Life Sciences Co., Ltd. (002004.SZ)

CNY 4.64

(-1.28%)

Market Cap (In CNY)

9.23 Billion

Revenue (In CNY)

11.59 Billion

Net Income (In CNY)

302.12 Million

Avg. Volume

19.08 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.68-5.23
PE
35.15
EPS
0.13
Beta Value
0.483
ISIN
CNE000001JJ6
CUSIP
-
CIK
-
Shares
2024049103.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Hai An Zhang
Employee Count
-
Website
https://www.huapont.com.cn
Ipo Date
2004-06-25
Details
Huapont Life Sciences Co., Ltd. engages in the pharmaceutical and agrochemical businesses in China and internationally. The company is involved in the production and sale of pharmaceutical preparations and intermediates. It also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and ophthalmology, as well as health management products. In addition, the company provides pesticide technical, intermediate and preparation products, and GLP registration technical services. The company was formerly known as Huapont-Nutrichem Co., Ltd. and changed its name to Huapont Life Sciences Co., Ltd. in September 2015. Huapont Life Sciences Co., Ltd. was founded in 2001 and is based in Chongqing, China. Huapont Life Sciences Co., Ltd. was formerly a subsidiary of Huipont Tourism Co. Ltd.